Pharmaron-backed Zentalis Pharmaceuticals has now secured $147m altogether and will advance its breast cancer and solid tumour candidates through clinical trials.

China Union Holdings has invested in the clinical services provider, which was formed by Joinn Laboratories last year and which will put the cash into expanding manufacturing capacity.

Fashion hire service Style Theory collected the cash from existing investor SoftBank Ventures Asia, Paradise Group and Alpha JWC Ventures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sweetome has acquired corporate-backed short-term accommodation platforms City Home and iYoujia, with Tencent, Alibaba, Tujia and Trip.com scoring exits.

SoftBank's second Vision Fund could close 30% lower than its $98.6bn first fund as potential LPs continue negotiations with the corporate.

The 3D printing technology provider received $60m from Group 42 in the form of a series B1 investment that marks the corporate's third in a Chinese company this year.

Legend Capital returned as the RNA drug developer secured $28.8m in a round co-led by Panlin Capital and Trinity Innovation Fund.

Kooksoondang Brewery took part in a series B round for oncology antibody developer Hummingbird Bioscience as it prepares to move its lead assets into the clinic.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds